RMD 2.03% $35.15 resmed inc

Ozempic study for treatment of chronic kidney diseases was...

  1. 8 Posts.
    Ozempic study for treatment of chronic kidney diseases was halted early after showing signs of early success.
    Shares of Novo are up 6% so I guess all stocks negatively related to it have been dumped hard in US session.

 
watchlist Created with Sketch. Add RMD (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.